Status:
COMPLETED
Effectiveness and Safety of Preoperative Magnetic Detection of Non-palpable Breast Lesions
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Breast Diseases
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer is the most common cancer in women and also has the highest death rate. In 2018, 58,500 new cases were diagnosed in metropolitan France. It affects, in 8 out of 10 cases, women aged 50 a...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years
- Patient with non-palpable benign, atypical or cancerous lesions
- Preoperative biopsy
- Requiring surgical excision
- French speaking patient
Exclusion
- Palpable breast lesion
- Contraindication to the installation of a magnetic tracer
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under court protection
- Patient opposing the use of his data for this research
Key Trial Info
Start Date :
March 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 6 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05327218
Start Date
March 20 2022
End Date
March 6 2023
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014